News PRISM BioLab Announces Patent Acquisition for PepMetics® Technology Library Compounds June 9, 2025 By vera PRISM BioLab is pleased to announce that we obtained a patent for our novel compound library on May 30th, 2025. For more details, please click here (Japanese language PDF). ← PreviousEisai to Present E7386, Co-created by PRISM BioLab and Eisai, at the ASCO (American Society of Clinical Oncology) Annual MeetingNext →Notice of Termination of Collaboration and Licensing Agreement with Eli Lilly and Company